0001968582-24-000094.txt : 20240207 0001968582-24-000094.hdr.sgml : 20240207 20240207161546 ACCESSION NUMBER: 0001968582-24-000094 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 24604501 BUSINESS ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-262-7002 MAIL ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Derakhshan Behrad CENTRAL INDEX KEY: 0001853109 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 144 1 primary_doc.xml 144 0001853109 XXXXXXXX LIVE 0001710072 Edgewise Therapeutics, Inc. 001-40236 1715 38th Street Boulder Boulder CO 80301 720-262-7002 Behrad Derakhshan Officer Common J.P. Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

10000 200000 63461608 02/07/2024 Nasdaq Common 02/07/2024 Stock Option Exercise Issuer N 10000 02/07/2024 Cash Y The sales under this filing are from Cashless Option Exercises that will occur within 3 months from the date of filings. 02/07/2024 03/30/2023 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Behrad Derakhshan